Concepts (226)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Carcinoma, Squamous Cell | 6 | 2020 | 1105 | 0.830 |
Why?
|
| Head and Neck Neoplasms | 5 | 2020 | 1089 | 0.750 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2022 | 190 | 0.620 |
Why?
|
| Chemoradiotherapy | 2 | 2020 | 327 | 0.550 |
Why?
|
| Cisplatin | 1 | 2020 | 611 | 0.540 |
Why?
|
| Tertiary Care Centers | 1 | 2014 | 128 | 0.390 |
Why?
|
| Skin Ulcer | 1 | 2012 | 27 | 0.380 |
Why?
|
| Hodgkin Disease | 1 | 2012 | 170 | 0.360 |
Why?
|
| Adenosine Deaminase | 1 | 2011 | 27 | 0.330 |
Why?
|
| Uric Acid | 1 | 2011 | 137 | 0.320 |
Why?
|
| C-Reactive Protein | 1 | 2011 | 206 | 0.310 |
Why?
|
| Skin | 1 | 2012 | 605 | 0.300 |
Why?
|
| Mouth Neoplasms | 3 | 2020 | 202 | 0.290 |
Why?
|
| Lymph Nodes | 1 | 2012 | 565 | 0.290 |
Why?
|
| Naegleria fowleri | 1 | 2008 | 1 | 0.290 |
Why?
|
| Central Nervous System Protozoal Infections | 1 | 2008 | 1 | 0.290 |
Why?
|
| Amebiasis | 1 | 2008 | 3 | 0.290 |
Why?
|
| Registries | 1 | 2014 | 986 | 0.280 |
Why?
|
| Mouth Mucosa | 2 | 2015 | 71 | 0.280 |
Why?
|
| India | 6 | 2020 | 138 | 0.220 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 4 | 2013 | 2642 | 0.220 |
Why?
|
| Leiomyosarcoma | 2 | 2015 | 49 | 0.200 |
Why?
|
| Pharyngeal Diseases | 1 | 2003 | 10 | 0.200 |
Why?
|
| Granuloma, Giant Cell | 1 | 2003 | 5 | 0.200 |
Why?
|
| Bone Diseases | 1 | 2003 | 54 | 0.200 |
Why?
|
| Sigmoid Neoplasms | 1 | 2002 | 9 | 0.190 |
Why?
|
| Humans | 36 | 2023 | 96105 | 0.190 |
Why?
|
| Adenocarcinoma, Mucinous | 1 | 2002 | 50 | 0.190 |
Why?
|
| Carcinoma | 2 | 2023 | 448 | 0.180 |
Why?
|
| Teratoma | 4 | 2010 | 58 | 0.180 |
Why?
|
| Adult | 16 | 2020 | 28721 | 0.180 |
Why?
|
| Tomography, X-Ray Computed | 8 | 2012 | 2777 | 0.180 |
Why?
|
| Neoplasm Staging | 3 | 2020 | 2086 | 0.180 |
Why?
|
| Penile Neoplasms | 2 | 2015 | 19 | 0.180 |
Why?
|
| Sclerotherapy | 1 | 2001 | 16 | 0.170 |
Why?
|
| Esophageal and Gastric Varices | 1 | 2001 | 36 | 0.170 |
Why?
|
| Abnormalities, Radiation-Induced | 1 | 2001 | 2 | 0.170 |
Why?
|
| Male | 22 | 2023 | 45863 | 0.170 |
Why?
|
| Female | 22 | 2023 | 50028 | 0.170 |
Why?
|
| Esophageal Diseases | 1 | 2001 | 26 | 0.170 |
Why?
|
| Aged | 13 | 2020 | 20968 | 0.170 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2022 | 188 | 0.170 |
Why?
|
| Esophagus | 1 | 2001 | 111 | 0.160 |
Why?
|
| Pancreatectomy | 1 | 2001 | 168 | 0.160 |
Why?
|
| Combined Modality Therapy | 5 | 2020 | 1773 | 0.160 |
Why?
|
| Middle Aged | 16 | 2023 | 28368 | 0.160 |
Why?
|
| Neoplasms | 2 | 2014 | 3248 | 0.160 |
Why?
|
| Attitude to Health | 1 | 2001 | 226 | 0.150 |
Why?
|
| Placenta | 1 | 2001 | 191 | 0.150 |
Why?
|
| Neoadjuvant Therapy | 1 | 2022 | 449 | 0.150 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2020 | 569 | 0.150 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2001 | 246 | 0.140 |
Why?
|
| Ethanol | 1 | 2001 | 270 | 0.140 |
Why?
|
| Prospective Studies | 5 | 2023 | 4671 | 0.140 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2001 | 358 | 0.140 |
Why?
|
| Survival Rate | 3 | 2020 | 1985 | 0.130 |
Why?
|
| Patient Safety | 1 | 2020 | 223 | 0.130 |
Why?
|
| Disease-Free Survival | 1 | 2020 | 1196 | 0.130 |
Why?
|
| Young Adult | 4 | 2014 | 7025 | 0.130 |
Why?
|
| Follow-Up Studies | 5 | 2014 | 3927 | 0.130 |
Why?
|
| Penis | 2 | 2015 | 65 | 0.120 |
Why?
|
| Socioeconomic Factors | 2 | 2014 | 640 | 0.120 |
Why?
|
| Hoarseness | 1 | 2015 | 11 | 0.120 |
Why?
|
| Vocal Cords | 1 | 2015 | 27 | 0.120 |
Why?
|
| Pancreatic Neoplasms | 1 | 2001 | 725 | 0.120 |
Why?
|
| Child | 7 | 2014 | 7625 | 0.110 |
Why?
|
| Laryngeal Neoplasms | 1 | 2015 | 89 | 0.110 |
Why?
|
| Doxorubicin | 2 | 2013 | 304 | 0.110 |
Why?
|
| Prognosis | 4 | 2023 | 4028 | 0.110 |
Why?
|
| Positron-Emission Tomography | 2 | 2013 | 353 | 0.100 |
Why?
|
| Eosinophilic Granuloma | 1 | 2013 | 11 | 0.100 |
Why?
|
| Family Characteristics | 1 | 2014 | 52 | 0.100 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2023 | 1172 | 0.100 |
Why?
|
| Colitis, Ulcerative | 1 | 2001 | 801 | 0.100 |
Why?
|
| Radiotherapy Planning, Computer-Assisted | 3 | 2005 | 204 | 0.100 |
Why?
|
| Adolescent | 7 | 2014 | 9895 | 0.100 |
Why?
|
| Demography | 1 | 2014 | 189 | 0.100 |
Why?
|
| Vagus Nerve Diseases | 1 | 2012 | 1 | 0.100 |
Why?
|
| Cranial Nerve Neoplasms | 1 | 2012 | 13 | 0.100 |
Why?
|
| Vinblastine | 1 | 2012 | 100 | 0.100 |
Why?
|
| Bleomycin | 1 | 2012 | 103 | 0.090 |
Why?
|
| Neurilemmoma | 1 | 2012 | 41 | 0.090 |
Why?
|
| Mouth Diseases | 1 | 2012 | 16 | 0.090 |
Why?
|
| Dacarbazine | 1 | 2012 | 101 | 0.090 |
Why?
|
| Opportunistic Infections | 1 | 2012 | 60 | 0.090 |
Why?
|
| Treatment Outcome | 5 | 2020 | 9175 | 0.090 |
Why?
|
| Plants, Medicinal | 1 | 2011 | 40 | 0.090 |
Why?
|
| Melanoma | 1 | 2015 | 497 | 0.090 |
Why?
|
| Mycoses | 1 | 2011 | 47 | 0.080 |
Why?
|
| Ondansetron | 1 | 2010 | 21 | 0.080 |
Why?
|
| Serotonin Antagonists | 1 | 2010 | 35 | 0.080 |
Why?
|
| Quinuclidines | 1 | 2010 | 26 | 0.080 |
Why?
|
| Antineoplastic Agents | 2 | 2020 | 2418 | 0.080 |
Why?
|
| Isoquinolines | 1 | 2010 | 73 | 0.080 |
Why?
|
| Anti-Infective Agents | 1 | 2011 | 96 | 0.080 |
Why?
|
| Lung Neoplasms | 1 | 2023 | 2463 | 0.080 |
Why?
|
| Drug Therapy, Combination | 2 | 2010 | 813 | 0.080 |
Why?
|
| Retroperitoneal Neoplasms | 1 | 2010 | 43 | 0.080 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2013 | 319 | 0.080 |
Why?
|
| Bacterial Infections | 1 | 2011 | 185 | 0.080 |
Why?
|
| Antiemetics | 1 | 2010 | 103 | 0.080 |
Why?
|
| Plant Extracts | 1 | 2011 | 248 | 0.070 |
Why?
|
| Nausea | 1 | 2010 | 182 | 0.070 |
Why?
|
| Biopsy | 1 | 2012 | 1220 | 0.070 |
Why?
|
| Dexamethasone | 1 | 2010 | 351 | 0.070 |
Why?
|
| Ceftazidime | 1 | 2008 | 8 | 0.070 |
Why?
|
| Amphotericin B | 1 | 2008 | 37 | 0.070 |
Why?
|
| Cerebrospinal Fluid | 1 | 2008 | 30 | 0.070 |
Why?
|
| Rifampin | 1 | 2008 | 23 | 0.070 |
Why?
|
| Treatment Refusal | 1 | 2008 | 68 | 0.070 |
Why?
|
| Empyema | 1 | 2007 | 9 | 0.070 |
Why?
|
| Fatal Outcome | 1 | 2008 | 304 | 0.070 |
Why?
|
| Chin | 1 | 2007 | 9 | 0.070 |
Why?
|
| Cleft Lip | 1 | 2007 | 16 | 0.070 |
Why?
|
| Abscess | 1 | 2007 | 95 | 0.060 |
Why?
|
| Aged, 80 and over | 3 | 2014 | 7229 | 0.060 |
Why?
|
| Neutrophils | 2 | 2023 | 332 | 0.060 |
Why?
|
| Radiotherapy Dosage | 4 | 2012 | 482 | 0.060 |
Why?
|
| Brain Neoplasms | 1 | 1990 | 854 | 0.050 |
Why?
|
| Radiation Injuries | 1 | 2005 | 163 | 0.050 |
Why?
|
| Sex Distribution | 2 | 2001 | 175 | 0.050 |
Why?
|
| Risk Assessment | 2 | 2001 | 2480 | 0.050 |
Why?
|
| Angiogenesis Inducing Agents | 1 | 2003 | 30 | 0.050 |
Why?
|
| Skull Base | 1 | 2003 | 52 | 0.050 |
Why?
|
| Surveys and Questionnaires | 2 | 2020 | 2860 | 0.050 |
Why?
|
| Androgen Antagonists | 1 | 2003 | 144 | 0.050 |
Why?
|
| Radiation Dosage | 2 | 2000 | 236 | 0.050 |
Why?
|
| Laparotomy | 1 | 2001 | 69 | 0.040 |
Why?
|
| Sclerosing Solutions | 1 | 2001 | 5 | 0.040 |
Why?
|
| Biopsy, Needle | 1 | 2001 | 231 | 0.040 |
Why?
|
| Tissue Extracts | 1 | 2001 | 25 | 0.040 |
Why?
|
| Mucous Membrane | 1 | 2001 | 85 | 0.040 |
Why?
|
| Prostate-Specific Antigen | 1 | 2003 | 346 | 0.040 |
Why?
|
| Lymphocytes | 1 | 2023 | 489 | 0.040 |
Why?
|
| Esophagoscopy | 1 | 2001 | 91 | 0.040 |
Why?
|
| Age Distribution | 1 | 2001 | 209 | 0.040 |
Why?
|
| Breast Neoplasms | 2 | 2007 | 3157 | 0.040 |
Why?
|
| Tobacco Use | 1 | 2020 | 31 | 0.040 |
Why?
|
| Colorectal Neoplasms | 1 | 2009 | 1069 | 0.040 |
Why?
|
| Health Surveys | 1 | 2001 | 245 | 0.040 |
Why?
|
| Incidence | 2 | 2001 | 1715 | 0.040 |
Why?
|
| Patient Participation | 1 | 2001 | 242 | 0.040 |
Why?
|
| Dengue | 1 | 1998 | 51 | 0.040 |
Why?
|
| Disease Outbreaks | 1 | 1998 | 157 | 0.030 |
Why?
|
| Tongue Neoplasms | 1 | 1997 | 51 | 0.030 |
Why?
|
| Lung | 1 | 2023 | 1384 | 0.030 |
Why?
|
| Glottis | 1 | 2015 | 13 | 0.030 |
Why?
|
| Sphenoid Bone | 1 | 1995 | 9 | 0.030 |
Why?
|
| Larynx | 1 | 2015 | 35 | 0.030 |
Why?
|
| Ependymoma | 1 | 1995 | 29 | 0.030 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 1995 | 107 | 0.030 |
Why?
|
| Meningioma | 1 | 1995 | 68 | 0.030 |
Why?
|
| Meningeal Neoplasms | 1 | 1995 | 73 | 0.030 |
Why?
|
| Spinal Cord Neoplasms | 1 | 1995 | 81 | 0.030 |
Why?
|
| Radiography, Panoramic | 1 | 2013 | 7 | 0.030 |
Why?
|
| Gingiva | 1 | 2013 | 8 | 0.030 |
Why?
|
| Retrospective Studies | 3 | 2023 | 10287 | 0.030 |
Why?
|
| Prednisolone | 1 | 2013 | 37 | 0.030 |
Why?
|
| Vincristine | 1 | 2013 | 113 | 0.030 |
Why?
|
| Cyclophosphamide | 1 | 2013 | 313 | 0.020 |
Why?
|
| Proteus Infections | 1 | 2012 | 1 | 0.020 |
Why?
|
| Candidiasis, Oral | 1 | 2012 | 4 | 0.020 |
Why?
|
| Staphylococcus epidermidis | 1 | 2012 | 16 | 0.020 |
Why?
|
| Fungemia | 1 | 2012 | 16 | 0.020 |
Why?
|
| Aspergillosis | 1 | 2012 | 39 | 0.020 |
Why?
|
| Escherichia coli Infections | 1 | 2012 | 36 | 0.020 |
Why?
|
| Klebsiella Infections | 1 | 2012 | 32 | 0.020 |
Why?
|
| Leukocyte Count | 1 | 2012 | 228 | 0.020 |
Why?
|
| Prostatic Neoplasms | 1 | 2003 | 1798 | 0.020 |
Why?
|
| Pseudomonas Infections | 1 | 2012 | 95 | 0.020 |
Why?
|
| Bacteremia | 1 | 2012 | 108 | 0.020 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2011 | 153 | 0.020 |
Why?
|
| Fungi | 1 | 2011 | 67 | 0.020 |
Why?
|
| Radiation Protection | 1 | 1990 | 28 | 0.020 |
Why?
|
| Recurrence | 1 | 2013 | 1218 | 0.020 |
Why?
|
| Skin Neoplasms | 1 | 2015 | 625 | 0.020 |
Why?
|
| alpha-Fetoproteins | 1 | 2010 | 46 | 0.020 |
Why?
|
| Cross-Over Studies | 1 | 2010 | 397 | 0.020 |
Why?
|
| Radiography, Abdominal | 1 | 2010 | 68 | 0.020 |
Why?
|
| Staphylococcal Infections | 1 | 2012 | 289 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2013 | 1619 | 0.020 |
Why?
|
| Nigeria | 1 | 2010 | 162 | 0.020 |
Why?
|
| Infant | 2 | 2010 | 3363 | 0.020 |
Why?
|
| Vomiting | 1 | 2010 | 201 | 0.020 |
Why?
|
| Child, Preschool | 2 | 2010 | 3974 | 0.020 |
Why?
|
| Acute Disease | 1 | 2010 | 872 | 0.020 |
Why?
|
| Animals | 1 | 2008 | 28891 | 0.020 |
Why?
|
| Infant, Newborn | 2 | 2007 | 2614 | 0.020 |
Why?
|
| Biomarkers, Tumor | 2 | 2010 | 1670 | 0.020 |
Why?
|
| Rectum | 1 | 2009 | 151 | 0.020 |
Why?
|
| Bacteria | 1 | 2011 | 517 | 0.020 |
Why?
|
| Palliative Care | 1 | 2009 | 273 | 0.020 |
Why?
|
| Colon | 1 | 2009 | 541 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2012 | 3110 | 0.010 |
Why?
|
| Fluoroscopy | 1 | 2005 | 138 | 0.010 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 1 | 1985 | 58 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2007 | 744 | 0.010 |
Why?
|
| Respiratory Insufficiency | 1 | 2007 | 205 | 0.010 |
Why?
|
| Testicular Neoplasms | 1 | 1985 | 123 | 0.010 |
Why?
|
| Mammography | 1 | 2007 | 475 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 1995 | 3639 | 0.010 |
Why?
|
| Comorbidity | 1 | 2007 | 1011 | 0.010 |
Why?
|
| Platelet Factor 4 | 1 | 2003 | 10 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factors | 1 | 2003 | 55 | 0.010 |
Why?
|
| Endothelial Growth Factors | 1 | 2003 | 55 | 0.010 |
Why?
|
| Lymphokines | 1 | 2003 | 75 | 0.010 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2003 | 60 | 0.010 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2003 | 190 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2003 | 380 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2003 | 296 | 0.010 |
Why?
|
| Time Factors | 1 | 2010 | 5580 | 0.010 |
Why?
|
| Risk Factors | 1 | 2012 | 5961 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2003 | 403 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2005 | 1158 | 0.010 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2003 | 299 | 0.010 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2000 | 192 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2003 | 938 | 0.010 |
Why?
|
| Age of Onset | 1 | 2001 | 344 | 0.010 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2000 | 315 | 0.010 |
Why?
|
| Climate | 1 | 1998 | 61 | 0.010 |
Why?
|
| Mastectomy | 1 | 2000 | 270 | 0.010 |
Why?
|
| Parotid Gland | 1 | 1997 | 26 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1997 | 271 | 0.010 |
Why?
|
| Antibodies, Viral | 1 | 1998 | 348 | 0.010 |
Why?
|
| Spinal Cord | 1 | 1995 | 252 | 0.010 |
Why?
|
| Dysgerminoma | 1 | 1985 | 7 | 0.000 |
Why?
|